Evidence map›Paper›PMID 40942332›Full record

ArticlePolymers2025

Mechanistic Insights into the Non-Monotonic Flame Retardancy of CPVC/ABS Composite.

Long Zhang, Lewen Liu, Shengwen Zou, Peng Qin, Zhengzhu Zhu, Shaoyun Guo, Qining Ke

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Long ZhangKingfa Science and Technology, Co., Ltd., Guangzhou 510663, China.
Lewen LiuKingfa Science and Technology, Co., Ltd., Guangzhou 510663, China.
Shengwen ZouKingfa Science and Technology, Co., Ltd., Guangzhou 510663, China.
Peng QinKingfa Science and Technology, Co., Ltd., Guangzhou 510663, China.
Zhengzhu ZhuKingfa Science and Technology, Co., Ltd., Guangzhou 510663, China.
Shaoyun GuoNational Key Laboratory of Advanced Polymer Materials, Sichuan University Polymer Research Institute, Sichuan University, Chengdu 610065, China.
Qining KeKingfa Science and Technology, Co., Ltd., Guangzhou 510663, China.ORCID 0000-0002-7941-9239

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chlorinated polyvinyl chloride (CPVC)/acrylonitrile-butadiene-styrene (ABS) composite represents an important class of engineering thermoplastics, offering a strong balance of flame retardancy, chemical resistance, mechanical properties, processability, and cost efficiency. Despite its widespread application, the flame-retardant mechanism in the CPVC/ABS system remains poorly understood. This work systematically investigated the non-monotonic flame-retardant behavior of CPVC/ABS composites through comprehensive characterization. The combustion performance, as determined by limiting oxygen index (LOI), UL-94 vertical burning tests, and cone calorimeter tests (CCTs), showed an unexpected pattern of flame retardancy initially improving then decreasing with reduced ABS content, which contradicted conventional expectations. The optimal composition at a CPVC/ABS ratio of 2:3 demonstrated good performance, achieving a UL-94 5VA rating and 47.3% reduction in total heat release (THR) relative to CPVC. A more stable and compact structure was observed from the morphology analysis of the residual char, and the thermogravimetric analysis further revealed a synergistic effect in carbonization behavior. The above flame-retardant mechanism could be interpreted by the combined effects of accelerated char formation during the early decomposition stage and significantly enhanced char crosslinking degree. These findings provided fundamental insights for designing high-performance flame-retardant polymer composites and facilitating their industrial implementation.

Indexed as

chlorinated polyvinyl chloride/acrylonitrile–butadiene–styrene compositeflame retardancyflame-retardant mechanismsynergistic effect

Identifiers

PMID40942332
PMCPMC12431173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.